This study suggests that primary care diagnosis and treatment with antihistamines, plus azithromycin in selected cases, may treat COVID-19 and prevent progression to severe disease in elderly patients
Keywords: SARS-CoV-2; Coronavirus; Azithromycin; Antihistamines; Elderly
Summary of the work in pdf
Summary of the work done by Yepes’ doctors and published in January 2021 in a North American scientific journal, explained in simple language.
Description of the Study:
- Title: Antihistamines and azithromycin as a treatment for COVID-19 on primary health care – A retrospective observational study in elderly patients.
- Principal investigators: Juan Ignacio Morán Blanco, Judith A. Alvarenga Bonilla, Sakae Homma, Kazuo Suzuki, Philip Fremont-Smith and Karina Villar Gómez de las Heras.
- Centers of Implementation: Two nursing homes in a rural area of Toledo.
- Study Population: 84 elderly patients diagnosed with COVID-19 and 64 employees located in two separate nursing homes.
- Study Type: Retrospective observational study.
- Design: A retrospective observational study of a case series of 84 elderly patients diagnosed with COVID-19, living in two nursing homes in a rural area of Toledo. The study period runs from the beginning of March to the end of June 2020.
Objectives of the Study:
Principal Objective: To evaluate the effectiveness of early COVID-19 treatment using a combination of antihistamines and azithromycin in elderly patients, to control the disease at Primary Health Care level. Fatality, hospital, and ICU admission rates from this case series are compared with Spanish official metrics for this patient population.
More about this Study:
Between March and April 2020, 84 elderly patients with suspected COVID-19 living in two nursing homes of Yepes, Toledo (Spain) were treated early with antihistamines (dexchlorpheniramine, cetirizine or loratadine), adding azithromycin in the 25 symptomatic cases.
The primary endpoint is the fatality rate of COVID-19. The secondary endpoints are the hospital and ICU admission rates. Endpoints were compared with the official Spanish rates for the elderly. The mean age of the study population was 85 and 48% were over 80 years old. No hospital admissions, deaths, nor adverse drug effects were reported in the patient population. By the end of June, 100% of the residents had positive serology for COVID-19.
The study was classified by the AEMPS (Spanish Agency of Medicines and Medical Devices) and approved by the Clinical Research Ethics Committee of the IIS-FJD (Madrid).
Other Epidemiological Studies:
MOOD-COVID aims to study the impact of the pandemic on the mental health of pregnant women, young mothers and their children.
This study aims to analyse the emotional and spiritual state of adults who have lost a loved one due to COVID-19.
This study aims to assess the mental health impact and needs associated with COVID-19 in Spain.
CIBERES UCI COVID is a fundamental study that will improve care of critical patients infected by COVID-19.
This study aims to identify socio-demographic factors, places frequented and behaviours associated with an increased risk of SARS-CoV-2 infection.
This study aims to determine the effects of vaccination against SARS-CoV-2 in people with long COVID.
The University Hospital of Tours has embarked on a large-scale survey to assess the psychological state of healthcare workers. It is a research project designed to map their disorders, but also to help them feel better.
Cross-sectional study that analyzes whether the COVID-19 pandemic has strongly impacted the practice of dentistry in Colombia, generating changes in clinical activities and career prospects.
Determining whether there is protection against reinfection is important for controlling healthcare workers implications during the pandemic due to their continous professional contact with COVID-19 patients
The Pasteur Institute hypothesizes in this study that there is no change in the transmissibility of the Delta variant related to climate during the study period (June 15 to October 1).